HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Pocoví Selected Research

LDL Receptors (LDL Receptor)

5/2010An NPC1L1 gene promoter variant is associated with autosomal dominant hypercholesterolemia.
9/2007Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
3/2003A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Pocoví Research Topics

Disease

6Gaucher Disease (Gaucher's Disease)
04/2003 - 11/2000
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
05/2010 - 06/2003
3Coronary Disease (Coronary Heart Disease)
11/2007 - 03/2003
3Hyperlipidemias (Hyperlipidemia)
09/2007 - 04/2001
2Cardiovascular Diseases (Cardiovascular Disease)
09/2011 - 06/2003
2Hypertension (High Blood Pressure)
09/2011 - 06/2003
2Inborn Genetic Diseases (Disease, Hereditary)
06/2003 - 03/2003
1Obesity
09/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2011
1Hypercholesterolemia
09/2007
1Diabetes Mellitus
06/2003
1Xanthomatosis (Xanthoma)
06/2003
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2003
1Tangier Disease
03/2003
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
07/2002
1Dyslipidemias (Dyslipidemia)
06/2002
1Alzheimer Disease (Alzheimer's Disease)
05/2001
1Schizophrenia (Dementia Praecox)
05/2001
1Atherosclerotic Plaque (Atheroma)
04/2001
1Atherosclerosis
04/2001
1Fibrosis (Cirrhosis)
11/2000
1Cicatrix (Scar)
11/2000
1Liver Diseases (Liver Disease)
08/2000
1Neurologic Manifestations (Neurological Manifestations)
08/2000

Drug/Important Bio-Agent (IBA)

4CholesterolIBA
09/2011 - 08/2000
4LipidsIBA
09/2007 - 04/2001
3LDL Receptors (LDL Receptor)IBA
05/2010 - 03/2003
3ApolipoproteinsIBA
05/2010 - 06/2003
3HDL CholesterolIBA
06/2003 - 08/2000
3Apolipoproteins E (ApoE)IBA
06/2003 - 05/2001
3Glucosylceramidase (Glucocerebrosidase)IBA
07/2002 - 03/2001
2Apolipoproteins B (ApoB)IBA
05/2010 - 09/2007
2Triglycerides (Triacylglycerol)IBA
06/2003 - 08/2000
2BezafibrateIBA
06/2002 - 04/2001
2Atorvastatin (Lipitor)FDA Link
06/2002 - 04/2001
2chitotriosidaseIBA
09/2001 - 04/2001
2EnzymesIBA
04/2001 - 03/2001
1gamma-sitosterol (beta-sitosterol)IBA
09/2011
1Phytosterols (Plant Sterols)IBA
09/2011
1Lipoprotein(a)IBA
11/2007
1SterolsIBA
09/2007
1Apolipoprotein B-100 (Apo B 100)IBA
09/2007
1LDL CholesterolIBA
06/2003
1algluceraseFDA Link
04/2003
1imigluceraseFDA Link
04/2003
1Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2003
1ATP Binding Cassette Transporter 1IBA
03/2003
1Proteins (Proteins, Gene)FDA Link
09/2001
1ChitinIBA
04/2001
1Biomarkers (Surrogate Marker)IBA
04/2001
1beta-GlucosidaseIBA
03/2001
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2000
1CytokinesIBA
11/2000
1Transforming Growth Factor beta (TGF-beta)IBA
11/2000
1Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2000
1Tartrate-Resistant Acid PhosphataseIBA
08/2000
1AcidsIBA
08/2000
1Acid PhosphataseIBA
08/2000
1Hemoglobins (Hemoglobin)IBA
08/2000
1GlycosidesIBA
08/2000

Therapy/Procedure

1Enzyme Replacement Therapy
04/2003
1Enzyme Therapy
04/2003
1Therapeutics
11/2000
1Orthopedic Procedures
08/2000